|
04 Jan 2007 |
D-Pharm announces positive Phase IIb trial results for DP-b99 in acute stroke patients
|
|
04 Jan 2007 |
Theravance Initiates Phase 2 Clinical Program with Investigational Heterodimer Antibiotic
|
|
04 Jan 2007 |
Catalyst Pharmaceutical Partners Provides an Update on Its Clinical Development Plans for CPP-109
|
|
04 Jan 2007 |
Aerovance Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients
|
|
04 Jan 2007 |
DURECT Starts Phase II Dosing for TRANSDUR(TM)-Bupivacaine (DUR-843)
|
|
04 Jan 2007 |
Poniard Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase 3 Trial of Picoplatin for Small Cell Lung Cancer
|
|
04 Jan 2007 |
Genaera Corporation Terminates Evizon(TM) Clinical Program And Restructures
|
|
03 Jan 2007 |
Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound
|
|
03 Jan 2007 |
Phase II clinical trial of Biomira's PX-12 in patients with advanced pancreatic cancer now open for patient enrollment
|
|
03 Jan 2007 |
Daiichi Sankyo, Inc. Announces Filing Of Supplemental New Drug Application For WelChol In The Treatment Of Type 2 Diabetes Mellitus
|
